Sernova Corp. (PSH.F)

0,2792 -0,0044 (-1,55%) Al cierre: 08:02AM CEST

Sernova Corp.

The Stiller Centre
Suite 114 700 Collip Circle
London, ON N6G 4X8
Canada
519 858 5126
https://www.sernova.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Ms. Cynthia Pussinen	CEO & Director	373,65k	N/A	N/A
Dr. Philip M. Toleikis B.A., M.Sc., Ph.D.	President, CTO, Director of Technology & Director	528,23k	N/A	N/A
Dr. Modestus Obochi M.B.A., Ph.D.	Chief Business Officer	204,65k	N/A	N/A
Dr. Frank Shannon M.D.	Vice President of Clinical Development & Regulatory Affairs	236,54k	N/A	N/A
Mr. Nicholas J. Rossettos CPA, M.B.A.	Interim Chief Financial Officer	N/A	N/A	1966
Mr. Douglas Maret	Chief Science Officer	N/A	N/A	N/A
Mr. Christopher Barnes	Vice President of Investor Relations	110,92k	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Gobierno corporativo

El ISS Governance QualityScore de Sernova Corp., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.